muscles primarily or secondarily. Eight of the patients treated for progressive muscular dystrophy by administration of glycine or creatine submitted to additional biopsies after receiving these substances for varying periods. Except where other muscles are mentioned, specimens were removed from the medial portion of the vastus externus.
Specimens were excised rapidly and prepared for analysis as described previously (17) . The trichloroacetic acid extract of muscle, prepared at 00 C., was analysed according to the procedure of Eggleton and Eggleton (9) for total acid soluble phosphorus, phosphocreatine (barium soluble fraction hydrolysed rapidly by acid at 200 C.), soluble ester phosphorus (the remainder of the barium soluble fraction after subtracting phosphocreatine), inorganic phosphate (directly determined barium insoluble fraction), and adenosine triphosphate (barium insoluble phosphate liberated by 7 minute hydrolysis at 1000 C. in normal acid). When it was not possible to prepare extracts of muscle in the cold, analyses of labile phosphate compounds were omitted. Phosphate was determined by the method of Fiske and Subbarow (10) and creatine by the method of Folin (11) . When sufficient material was available, determinations of fat, nitrogen, and water were included. Results are expressed in terms of fatfree muscle when the concentration of fat was known.
Clinical and necropsy findings (available in 3 cases) and results of microscopic examination of muscle were given consideration in establishing diagnoses. Protocols and salient details of microscopy of 8 patients have been described in the earlier article cited. Histological studies of muscle were made by Dr. R. P. Custer. 377
Chemical analyses of specimens of muscle of patients with progressive muscular dystrophy are shown in Table I with normal concentrations. Inorganic and soluble ester phosphorus, although decreased in concentration along with other fractions, constituted a larger proportion of the total acid soluble phosphorus in dystrophic muscle than in normal muscle. This relative gain was at the expense of phosphocreatine phosphate and adenosine triphosphate. Degeneration of muscle did not occur uniformly in progressive muscular dystrophy. Not only were certain groups of muscles affected before and with greater severity than others, but variation occurred within the muscle as well. Fibers in various stages of degeneration were seen together with normal fibers. Larger areas of muscle differed in concentration of creatine, phosphorus, and fat. The clinical effects of glycine therapy upon these patients have been described in our preceding article (17) which included also a brief summary of alterations occurring within the muscles. The examination of the muscles of patients suffering from progressive muscular dystrophy after varying periods of glycine feeding (up to 1 year) showed that decided abnormalities, both chemical and histological, persisted. However, higher concentrations of extractives found in muscle suggested that the glycine fed had stimulated regeneration of muscle. Unfortunately, only 8 patients could be induced to submit to serial biopsies and while 6 showed significant gains in chemical composition of muscle following treatment, this number is insufficient to exclude chance variation. Such improvement, if it may be so considered, was not manifested clinically despite the fact that glycine was administered for as long as 23 months to two patients. Similar trials with creatine showed no favorable effects. The composition of muscle remained unchanged or exhibited additional evidence of deterioration. The distribution of acid soluble phosphorus remained unaffected by either glycine or creatine therapy.
Analyses of muscle similar to those made in progressive muscular dystrophy have been made in other diseases involving the musculature to learn whether changes observed were peculiar to dystrophy or of more general occurrence (Table  III) . With the exception of one patient who had myasthenia gravis, and one with myositis, involvement of the muscles was caused either by impaired metabolism or by disease primarily of the nervous system.
In myasthenia gravis (Patient 33), the only distinctly abnormal result was the exceptionally high concentration of soluble ester phosphorus.
Nevin (16) also found this to be the sole noteworthy chemical change in muscle in this disease. Likewise, Collazo, Barbudo, and Torres (5) observed no distinctive deviation from normal in muscle of a patient suffering from severe myasthenia gravis. In Table III , it is seen that the concentration of creatine is not far from normal and not nearly as low as in progressive muscular dystrophy. While Williams and Dyke (19) reported lowered creatine concentrations in muscle in myasthenia gravis, the method employed fails to measure creatine quantitatively.
Osteitis fibrosa cystica (secondary to parathyroid adenoma), in Patient 34 whose muscles we examined, was accompanied by painful sensations and pronounced weakness in the voluntary muscles. Large amounts of creatine were excreted in the urine. Muscle creatine and phosphocreatine 
Specimens from muscle normal in function and appearance were secured from Patients 19 and 20 suspected of trichinosis, but in whom neither parasites nor inflammation of muscles were found, and also from a patient suffering from hypertensive cardiovascular disease. Creatine concentrations were within the limits of normal established by Bodansky (1) and Corsaro (6) in two patients, and lower in the third. Few figures are available for concentrations in human voluntary muscle of phosphocreatine and other fractions of the acid soluble phosphate. Nevin (16) has published analyses for these substances in 6 normal human subjects. Our values for phosphocreatine and inorganic orthophosphate agree well with those of Nevin; however, we find less adenosine triphosphate and more soluble ester phosphorus. Our data are similar to those of Eggleton (8), Milroy (15) and others who have analysed animal muscles.
DISCUSSION
The effect of disease upon the composition of muscle has not been investigated extensively. Brand and Harris (4), Nevin (16), Collazo, Barbudo, and Torres (5), and Debr'e, Marie, and Nachmansohn (7) have analysed phosphate compounds of the muscles of patients suffering from myopathies. The last named group determined glycogen and lactic acid as well. Low concentrations of creatine in muscle were found in myositis fibrosa by Bodansky, Schwab, and Brindley (2) and in myositis ossificans by Bodansky and Schwab (3) . Nevin (16) has compared a number of diseases in regard to muscle chemistry. Hines (16) . In his experiments, no decrease in adenosine triphosphate and little change in phosphocreatine occurred after stimulation of badly degenerated muscle. Muscles less severely involved showed an appreciable hydrolysis of phosphate compounds as did also normal muscle.
Presumably, deficiencies with respect to phosphocreatine and adenosine triphosphate were related since phosphorylation in muscle involves both in linked reactions. Interference at any of several steps in the phosphorylation process would lead to impairment of phosphocreatine resynthesis with diminished concentration of this substance. Loss of diffusion of creatine remaining uncombined would follow. Actually, we have found less creatine combined as phosphocreatine in most of the dystrophic muscles when comparison is made with muscles in other diseases studied.
Through the collaboration of Doctor William A. Wolff and Professor D. Wright Wilson, several specimens of biopsied muscle from patients with progressive muscular dystrophy were analysed by the colorimetric method for carnosine (13, 14) . It was found that carnosine was present although in low concentrations as compared with the normal. The 
